E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer
O Schmalhofer, S Brabletz, T Brabletz - Cancer and Metastasis Reviews, 2009 - Springer
The embryonic program 'epithelial-mesenchymal transition'(EMT) is activated during tumor
invasion in disseminating cancer cells. Characteristic to these cells is a loss of E-cadherin …
invasion in disseminating cancer cells. Characteristic to these cells is a loss of E-cadherin …
[HTML][HTML] Dietary long-chain n− 3 fatty acids for the prevention of cancer: a review of potential mechanisms
Increasing evidence from animal and in vitro studies indicates that n− 3 fatty acids,
especially the long-chain polyunsaturated fatty acids eicosapentaenoic acid and …
especially the long-chain polyunsaturated fatty acids eicosapentaenoic acid and …
COX-2 as a target for cancer chemotherapy
Abstract Cyclooxygenase-1 and-2 (COX-1/2) catalyze the initial step in the formation of
prostaglandins. Very recently their role in carcinogenesis has become more evident. They …
prostaglandins. Very recently their role in carcinogenesis has become more evident. They …
Cyclooxygenase-2: a novel target for cancer chemotherapy?
W Dempke, C Rie, A Grothey, HJ Schmoll - Journal of cancer research and …, 2001 - Springer
Epidemiologic studies have documented a 40–50% reduction in incidence of colorectal
cancer in individuals taking nonsteroidal antiinflammatory drugs (NSAIDs). Since NSAIDs …
cancer in individuals taking nonsteroidal antiinflammatory drugs (NSAIDs). Since NSAIDs …
Cyclooxygenase-2–Dependent Regulation of E-Cadherin: Prostaglandin E2 Induces Transcriptional Repressors ZEB1 and Snail in Non–Small Cell Lung Cancer
M Dohadwala, SC Yang, J Luo, S Sharma, RK Batra… - Cancer research, 2006 - AACR
Abstract Elevated tumor cyclooxygenase-2 (COX-2) expression is associated with tumor
invasion, metastasis, and poor prognosis in non–small cell lung cancer (NSCLC). Here, we …
invasion, metastasis, and poor prognosis in non–small cell lung cancer (NSCLC). Here, we …
Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44
M Dohadwala, J Luo, L Zhu, Y Lin, GJ Dougherty… - Journal of Biological …, 2001 - ASBMB
Elevated tumor cyclooxygenase (COX-2) expression is associated with increased
angiogenesis, tumor invasion, and suppression of host immunity. We have previously shown …
angiogenesis, tumor invasion, and suppression of host immunity. We have previously shown …
Cyclooxygenase-2 as a target for anticancer drug development
JB Méric, S Rottey, K Olaussen, JC Soria… - Critical reviews in …, 2006 - Elsevier
The two isoforms cyclooxygenase-1 and-2 catalyze the initial step in the formation of
prostaglandins in a variety of pathophysiological processes. More recently their role in …
prostaglandins in a variety of pathophysiological processes. More recently their role in …
Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent …
M Dohadwala, RK Batra, J Luo, Y Lin, K Krysan… - Journal of Biological …, 2002 - ASBMB
Tumor cyclooxygenase-2 (COX-2) expression is known to be associated with enhanced
tumor invasiveness. In the present study, we evaluated the importance of the COX-2 product …
tumor invasiveness. In the present study, we evaluated the importance of the COX-2 product …
Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia
E Fosslien - Critical reviews in clinical laboratory sciences, 2000 - Taylor & Francis
Several types of human tumors overexpress cyclooxygenase (COX)-2 but not COX-1, and
gene knockout transfection experiments demonstrate a central role of COX-2 in …
gene knockout transfection experiments demonstrate a central role of COX-2 in …
Peroxisome proliferator-activated receptor γ ligands suppress the transcriptional activation of cyclooxygenase-2: evidence for involvement of activator protein-1 and …
K Subbaramaiah, DT Lin, JC Hart… - Journal of Biological …, 2001 - ASBMB
We investigated whether peroxisome proliferator-activated receptor γ (PPARγ) ligands
(ciglitazone, troglitazone, and 15-deoxy-Δ 12, 14 prostaglandin J 2) inhibited …
(ciglitazone, troglitazone, and 15-deoxy-Δ 12, 14 prostaglandin J 2) inhibited …